Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice, comprehensive pice about belapectin. I'm long time investor and believer. Still we need lot of patience. Ph3 trial will take long time. Buyout possible on cancer data
I wonder where is Staccani now
That's true, this is still dilution. Good thing it puts the floor right under price I paid year ago 2.36
Tesla is totally different story, different technology and especially different target. It's like to compare Intel to ford
My point is PLUG is far away from being profitable, last quarter showed the light in the tunnel, but still there is long way to go, with possible dillutions on the way.
Not talking about Tesla here
They are EBITA positive, but still have big net loss
So far there is NO PROFIT in them. Even with tax cuts. Maybe in the future, and maybe PLUG, big maybe.
What you believe is one thing, financial are the other and they are still negative.plus hydrogen is not fuel, it's a way to store energy.
Take A look 33% keytruba alone, 50% with GALT. That's almost 50% better response rate.
But still it is 17%more than keytruba alone plus 2 patients stabilized makes over 60. Not bad for hard to treat patients.
Plus this is only 1b trial about safety. There is some room to play with dosage and length of the therapy.
Now I wonder if this pop today is because of blog you posted, or any other reason
Yes, you are right. Great, great news, for us and for them.
Great info. Good luck to them. On other side, tumor began shrinking before galectin infusion. How can they evaluate effectiveness of this drug?
What do you guys think about cancer trials? Last results were encouraging, but still this is cancer...
What do you guys think about cancer trials? Last results were encouraging, but still this is cancer...
?? picking
It doesn't work with Yervoy
What badders me why smaller dose works much better than higher. Then how to sell it to FDA?
Not necessarily. If they get partnership or buyout we fine.
Forget about it. It will go back down.
Thera are also melanoma results coming. I think before december.
What happened today? Why spiked?
But they act like they don't want/need a partner. Either they are so sure of results or so stupid.
Yup, he went all in !!!!!!
There is other explanation. Corporate greed. And this may be the reason why Ulhaim sells his stocks, which was for him some kind of charity donation.
Why do they need this offering now? Traber s salary?
Any thoughts/leaks about tomorrow's earnings?
... "Galectin, which expects key data in December, has commenced preliminary partnership discussions, its chief operating officer told Reuters." ....
I hope it's true. ...
Or they will come with offering. They need money for Trabers salary.
This is the rison, I think...
http://labiotech.eu/galecto-biotech-bms-td139-phase-ia-iib/
Don't you think Traber is so sure of the CX trial result that he don't want/need partnership. If he is right, in the long term, we are better without partnership, because we don't have to share the profits with big pharma. Does it make sense?
How far it will go??
This thing pops more on technicals and sentiment than on news...
It works either way, isn't it?
:)))))))))
Let's hope his ego is as big as his medical knowledge.
Really good article. lot of info, lot of work. I hope hi is right. Plus I didn't know that drug can be approved and on market in the middle of 2018.